Vycor Medical (VYCO) Gains from Investment Securities (2017 - 2019)
Vycor Medical's (VYCO) quarterly Gains from Investment Securities came in at $749.0 in Q2 2019, up 723.08% year-over-year from $91.0 in Q2 2018, and up 723.08% quarter-over-quarter from $91.0 in Q2 2018.
Powered by 
Analysis
Vycor Medical (VYCO) Gains from Investment Securities (2017 - 2019) Analysis & Trends
Vycor Medical (VYCO) has reported Gains from Investment Securities for 3 consecutive years, with $749.0 the latest figure, recorded in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 749.00 |
| Jun 30, 2018 | 91.00 |
| Sep 30, 2017 | -646.00 |